(MENAFN- Swissinfo)
Around 69% of the Swiss population have so far received two doses of vaccine. Keystone / Gian Ehrenzeller
The Swiss authorities have recommended that people aged over 16, especially the most vulnerable, get a Covid-19 booster shot to contain a new wave of infections expected this autumn and winter.
This content was published on September 9, 2022 - 12:01 September 9, 2022 - 12:01 SRF/FOPH/swissinfo.ch/sb
After a rise in new Covid infections in June and July due to new Omicron subvariants, cases have fallen andExternal link stabilised at a“relatively low level” in Switzerland, the Federal Office of Public Health (FOPH) saidExternal link on Friday. The number of hospital admissions is also down.
“However, based on experiences so far with SARS-CoV-2, an increase in transmissions of the virus is expected from the fall [autumn] of 2022. The risk of contracting COVID-19 and the burden for the health system could therefore increase again,” it said.
The Swiss authorities therefore recommend as a priority that people aged 65 or over, and those aged 16 to 64 with an increased risk, for example anyone with a pre-existing disease or pregnant women, get a Covid booster shot this autumn. This recommendation also applies to healthcare workers.
For anyone aged 16-64 without risk factors, a booster vaccination“makes sense after individual assessment… to reduce the risk of a serious and rare infection”, FOPH said.
Young people, aged 5-15, do not need a booster jab, as Covid symptoms are generally light or non-existent, according to the authorities. Young people who have already been infected have sufficient antibodies 16 months after getting the virus. No vaccine authorisation has been issued in Switzerland for the under-fives.
The authorities recommend both mRNA Covid vaccines, such as those from Pfizer/BioNTech or Moderna, and the protein-based Nuvaxovid vaccine as boosters. New so-called bivalent mRNA vaccines, which are tailored to the BA.1 version of Omicron and the original virus first detected in China, should be preferred for booster vaccination. But it is still possible to use the current monovalent mRNA vaccine, FOPH said.
Switzerland will receive three and a half million doses of the bivalent vaccine Spikevax from Moderna by the end of September.
MENAFN10092022000210011054ID1104841782
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.